We curate a digest of the latest news in our field for advocates, policymakers, community coalitions and all who work toward shaping policies and practices to effectively prevent substance use and treat addiction.
Young adults with substance use disorder and a co-occurring psychiatric disorder should receive integrated mental health and addiction care across treatment settings, according to new principles of care released by a group of pediatric addiction medicine experts.
Young man holding and vaping an electronic cigarette, e-cig, ecigarette.
The incoming Biden-Harris administration can end the tobacco industry’s longstanding hold on serious tobacco control efforts, which has largely been tolerated by past administrations.
Fentanyl overdoses played a large role in the sharp increase in the deaths of homeless people in Los Angeles County last year, according to a new report.
More than 81,000 Americans died from a drug overdose during the 12 months ending in May, the highest number ever recorded during a 12-month period, according to new data from the U.S. Centers for Disease Control and Prevention.
Changes in federal rules that made it easier to prescribe the opioid addiction medicine buprenorphine during the early days of the pandemic led to an increase in the number of patients receiving the medication in Texas, HealthDay reports.
Almost two-thirds of people who smoke four or fewer cigarettes a day are addicted to nicotine, a new study finds. The results indicate that lighter smoking is still risky, the researchers say.
Closeup of pharmaceutical medicine tablet pill production in the rails
Two members of the Sackler family, which owns OxyContin maker Purdue Pharma, were scheduled to testify Thursday before a House panel investigating the opioid epidemic, according to Reuters.
Nonprofit groups that advocate treating pain with medications have received $65 million since 1997 from opioid manufacturers, according to a bipartisan congressional investigation.
Teens’ rate of vaping nicotine and marijuana leveled off this year, but rates remain high, according to the most recent figures from the annual Monitoring the Future survey.
The consulting firm McKinsey & Company advised members of the Sackler family, the owners of OxyContin maker Purdue Pharma, to consider giving the company’s distributors a rebate for every overdose attributable to the pills they sold, according to documents released in a federal bankruptcy court.
Purdue Pharma pleaded guilty to federal criminal charges related to the marketing and distribution of its opioid painkiller OxyContin, The New York Times reports.
This website uses cookies. We use cookies and similar technologies to give you the best experience. By using this website, you accept our Privacy Policy and Terms of Use.
Get Support
